These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Angiotensin-converting enzyme inhibitors promote nitric oxide production in coronary microvessels from failing explanted human hearts. Kichuk MR; Zhang X; Oz M; Michler R; Kaley G; Nasjletti A; Hintze TH Am J Cardiol; 1997 Aug; 80(3A):137A-142A. PubMed ID: 9293967 [TBL] [Abstract][Full Text] [Related]
25. Combining lisinopril and l-arginine slows disease progression and reduces endothelin-1 in passive Heymann nephritis. Zoja C; Benigni A; Camozzi D; Corna D; Longaretti L; Todeschini M; Remuzzi G Kidney Int; 2003 Sep; 64(3):857-63. PubMed ID: 12911535 [TBL] [Abstract][Full Text] [Related]
26. Endothelium-derived bradykinin is responsible for the increase in calcium produced by angiotensin-converting enzyme inhibitors in human endothelial cells. Busse R; Lamontagne D Naunyn Schmiedebergs Arch Pharmacol; 1991 Jul; 344(1):126-9. PubMed ID: 1663586 [TBL] [Abstract][Full Text] [Related]
27. Effects of sulphydryl- and non-sulphydryl-containing ACE inhibitors on left ventricular relaxation in the isolated guinea pig heart. Anning PB; Grocott-Mason RM; Lewis MJ Endothelium; 1997; 5(4):265-75. PubMed ID: 9588818 [TBL] [Abstract][Full Text] [Related]
28. Is there a rationale for combining angiotensin-converting enzyme inhibitors and calcium antagonists in cardiovascular disease? Ruschitzka FT; Lüscher TF Am Heart J; 1997 Aug; 134(2 Pt 2):S31-47. PubMed ID: 9313622 [TBL] [Abstract][Full Text] [Related]
29. Endogenous bradykinin suppresses myocardial fibrosis through the cardiac-generated endothelin system under chronic angiotensin-converting enzyme inhibition in heart failure. Fujii M; Wada A; Ohnishi M; Tsutamoto T; Matsumoto T; Yamamoto T; Takayama T; Dohke T; Isono T; Eguchi Y; Horie M J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S346-9. PubMed ID: 15838317 [TBL] [Abstract][Full Text] [Related]
30. Coronary vasodilation induced by captopril and zofenoprilat: evidence for a prostaglandin-independent mechanism. van Wijngaarden J; Tio RA; van Gilst WH; de Graeff PA; de Langen CD; Wesseling H Naunyn Schmiedebergs Arch Pharmacol; 1991 May; 343(5):491-5. PubMed ID: 1881459 [TBL] [Abstract][Full Text] [Related]
32. Effect of angiotensin II type 1 receptor antagonism on endothelial function: role of bradykinin and nitric oxide. Landmesser U; Drexler H J Hypertens Suppl; 2006 Mar; 24(1):S39-43. PubMed ID: 16601572 [TBL] [Abstract][Full Text] [Related]
33. H Monti M; Terzuoli E; Ziche M; Morbidelli L Pharmacol Res; 2016 Nov; 113(Pt A):426-437. PubMed ID: 27650753 [TBL] [Abstract][Full Text] [Related]
34. Nitric oxide donors and angiotensin-converting enzyme inhibitors act in concert to inhibit human angiotensin-converting enzyme activity and platelet aggregation in vitro. Persson K; Whiss PA; Nyhlén K; Jacobsson-Strier M; Glindell M; Andersson RG Eur J Pharmacol; 2000 Oct; 406(1):15-23. PubMed ID: 11011027 [TBL] [Abstract][Full Text] [Related]
35. Arginine bioavailability and endothelin-1 system in the regulation of vascular function of umbilical vein endothelial cells from intrauterine growth restricted newborns. He Q; Liu X; Zhong Y; Xu SS; Zhang ZM; Tang LL; Zhang LY; Du LZ Nutr Metab Cardiovasc Dis; 2018 Dec; 28(12):1285-1295. PubMed ID: 30392707 [TBL] [Abstract][Full Text] [Related]
36. Postischemic antiarrhythmic effects of angiotensin-converting enzyme inhibitors. Role of suppression of endogenous endothelin secretion. Brunner F; Kukovetz WR Circulation; 1996 Oct; 94(7):1752-61. PubMed ID: 8840871 [TBL] [Abstract][Full Text] [Related]
37. Angiotensin-converting enzyme inhibitors improve coronary flow reserve in dilated cardiomyopathy by a bradykinin-mediated, nitric oxide-dependent mechanism. Nikolaidis LA; Doverspike A; Huerbin R; Hentosz T; Shannon RP Circulation; 2002 Jun; 105(23):2785-90. PubMed ID: 12057995 [TBL] [Abstract][Full Text] [Related]
38. Vascular effects of newer cardiovascular drugs: focus on nebivolol and ACE-inhibitors. Lüscher TF; Spieker LE; Noll G; Cosentino F J Cardiovasc Pharmacol; 2001 Dec; 38 Suppl 3():S3-11. PubMed ID: 11811390 [TBL] [Abstract][Full Text] [Related]
39. Effects of ACE-inhibition on redox status and expression of P-selectin of endothelial cells subjected to oxidative stress. Zahler S; Kupatt C; Möbert J; Becker BF; Gerlach E J Mol Cell Cardiol; 1997 Nov; 29(11):2953-60. PubMed ID: 9405170 [TBL] [Abstract][Full Text] [Related]
40. Local regulation of vascular tone by bradykinin and angiotensin converting enzyme inhibitors. Auch-Schwelk W; Kuchenbuch C; Claus M; Walther B; Bossaller C; Friedel N; Graf K; Gräfe M; Fleck E Eur Heart J; 1993 Nov; 14 Suppl I():154-60. PubMed ID: 8293767 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]